The University of Reading (England)
Marc Stapley joined Illumina in 2012 and holds the role of Executive Vice President, Strategy and Corporate Development, responsible for corporate strategy, corporate & business development and global infrastructure. Previously, Stapley served as Chief Administrative Officer with responsibility for all G&A functions. Prior to that, he served as Senior Vice President and Chief Financial Officer. He is also a member of Illumina’s executive management team, which is responsible for directing all aspects of company strategy, planning, and operations.
the University of Toronto
Mark Van Oene is Senior Vice President and Chief Commercial Officer for Illumina, a position he has held since 2017. He is responsible for the development and implementation of the company’s commercial strategy and is responsible for world-wide sales, services and marketing. Van Oene was previously Illumina’s Senior Vice President of the Americas region and subsequently named interim Chief Commercial Officer in late 2016. Van Oene joined Illumina in 2006 as Regional Account Manager for Canada. In 2008, he assumed the role of Senior Director of Sales for the Americas and was promoted to Vice President with responsibility for global sales in 2012. In early 2014, Van Oene was named the General Manager for the Americas region, advancing to Senior Vice President in April 2016.
McMaster University in Hamilton, Canad
Sam Samad joined Illumina in 2017 and holds the role of Senior Vice President and Chief Financial Officer with responsibility for the company’s finance, accounting, investor relations, internal audit, and treasury functions.
Before joining Illumina, Samad held several senior leadership positions at Cardinal Health including Senior Vice President and Corporate Treasurer, with leadership responsibility for Cardinal Health’s China business. He was previously Senior Vice President and Chief Financial Officer for the pharmaceutical segment, and Vice President, Healthcare Supply Chain Services. He also previously held finance roles at Eli Lilly and Pepsico Inc.